Add Company
Join Now

Longitude Capital Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • Longitude Capital's estimated annual revenue is currently $7.5M per year.(i)
  • Longitude Capital's estimated revenue per employee is $174,419

Employee Data

  • Longitude Capital has 43 Employees.(i)
  • Longitude Capital grew their employee count by -19% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M10-55%N/AN/A
#2
N/A35-3%N/AN/A
#3
$7.5M8-27%N/AN/A
#4
$3.5M7952%N/AN/A
#5
N/A110%N/AN/A
#6
$7.5M29-12%N/AN/A
#7
$15M43-16%N/AN/A
#8
$15M34N/AN/AN/A
#9
$7.5M2624%N/AN/A
#10
$15M24518%N/AN/A
Add Company

Longitude Capital is a life sciences venture capital firm specializing in investments in medical devices, biotechnology and pharmaceutical development. We consider companies across all therapeutic indications and stages of development. Founded in 2006, the firm consists of six investment professionals with more than 100 years of operating and venture capital investing experience. We are active, lead investors and work closely with our portfolio companies to build value.

keywords:N/A

N/A

Total Funding

43

Number of Employees

$7.5M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Longitude Capital's People

NameTitleEmail/Phone
1
Managing DirectorReveal Email/Phone
2
Managing DirectorReveal Email/Phone
3
Accounting ManagerReveal Email/Phone
4
Executive AssistantReveal Email/Phone
5
FP&A ConsultantReveal Email/Phone
6
VPReveal Email/Phone
7
VP FinanceReveal Email/Phone
8
Venture PartnerReveal Email/Phone
9
PrincipalReveal Email/Phone
10
Managing DirectorReveal Email/Phone

Longitude Capital News

2022-04-13 - Inozyme Pharma, Inc. (NASDAQ:INZY) Major Shareholder ...

Inozyme Pharma, Inc. (NASDAQ:INZY) Major Shareholder Longitude Capital Partners Iii Purchases 1,355,000 Shares. Posted by admin on Apr 21st, 2022.

2022-03-30 - LimFlow Raises $40 Million (€36 Million) in Series D Financing

New investors Longitude Capital, Soleus Capital Management and an undisclosed strategic investor joined the round along with current major...

2022-03-30 - IntelyCare collects $115m in Janus Henderson-led funding

Details: Other investors joining Janus in the round include Longitude Capital, Leeds Illuminate, Endeavour Vision, Revelation Partners and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.3M43-4%N/A
#2
$5M435%N/A
#3
$4.8M438%N/A
#4
$4.9M445%N/A
#5
$8M442%N/A